Skip to main content
Erschienen in: Cardiovascular Intervention and Therapeutics 2/2022

Open Access 13.07.2021 | Original Article

Percutaneous coronary intervention for left main coronary artery malperfusion in acute type A aortic dissection

verfasst von: Yuya Taguchi, Shunsuke Kubo, Akihiro Ikuta, Kohei Osakada, Makoto Takamatsu, Kotaro Takahashi, Masanobu Ohya, Takenobu Shimada, Katsuya Miura, Ryosuke Murai, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Tsuyoshi Goto, Tatsuhiko Komiya, Kazushige Kadota

Erschienen in: Cardiovascular Intervention and Therapeutics | Ausgabe 2/2022

Abstract

The clinical outcomes of patients undergoing percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) malperfusion caused by acute type A aortic dissection (AAAD) remains largely unexplored. The aim of this study was to determine the clinical outcomes of patients undergoing PCI for LMCA malperfusion caused by AAAD. We examined nine consecutive patients undergoing PCI for LMCA malperfusion caused by AAAD between 1995 and 2020. The mean age was 55.4 ± 7.7 years. Eight patients presented cardiogenic shock, and five patients cardiopulmonary arrest. Two patients were diagnosed with AAAD before coronary angiography using computed tomography and transthoracic echocardiography, respectively, and in the other seven patients after coronary angiography using other modalities. Four patients underwent PCI on intra-aortic balloon pumping support, and four patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) support, including one patient on both. PCI was successful in eight patients, with final thrombolysis in myocardial infarction grade 2 or 3. The four patients on VA-ECMO did not undergo aortic dissection repair due to poor recovery of cardiac function and died during the hospital stay, and the other five patients had successful PCI, underwent aortic dissection repair, and remained alive at 5 year follow-up. In conclusion, LMCA malperfusion caused by AAAD seemed to have clinical presentations and electrocardiogram changes similar to acute coronary syndrome. PCI and subsequent surgical aortic repair saved the lives of all AAAD patients with LMCA malperfusion who had not required VA-ECMO.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Aortic dissection is associated with cardiac tamponade, aortic regurgitation, and ischemia in various branches, depending on the progress of dissection. Coronary malperfusion is one of the fatal complications of acute type A aortic dissection (AAAD). The in-hospital mortality rate in AAAD patients without any complications ranges from 8 to 19%, whereas that in AAAD patients with coronary malperfusion ranges from 20 to 30% [13]. Malperfusion in the left main coronary artery (LMCA) is particularly associated with catastrophic outcomes, because it can cause cardiogenic shock or cardiac arrest [3, 4]. Immediate revascularization is necessary for AAAD patients with LMCA malperfusion to treat myocardial ischemia and provide hemodynamic stability.
The current guidelines suggest surgical resection and thoracic aorta replacement as the gold standard for the treatment of AAAD [5, 6]. According to previous research, any delay in the door-to-balloon time in patients with ST elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) is associated with higher in-hospital mortality [7], and preoperative PCI is effective for coronary malperfusion caused by AAAD [4, 812]. However, regarding LMCA malperfusion in AAAD, its analytical treatment data are scarce because of its low incidence, and, therefore, which treatment should take priority, surgical correction or reperfusion therapy, remains controversial.
Here we present a case series of patients undergoing PCI for LMCA malperfusion caused by AAAD, describe their in-hospital and long-term outcomes, and discuss the optimal treatment strategy.

Methods

This retrospective, single-center, observational study was based on an initial cohort of 10,530 consecutive patients with acute coronary syndrome undergoing emergent PCI between January 1995 and January 2020. In this cohort, we included patients with LMCA malperfusion caused by AAAD. Patients with right coronary artery malperfusion were not included. The study was done in accordance with the provision of the Declaration of Helsinki and the guidelines for epidemiological studies issued by the Ministry of Health, Labour, and Welfare of Japan. All the patients provided informed consent for the procedure and subsequent data collection, and the patients included in this case series provided consent for publication.

PCI procedures

When a patient was diagnosed with AAAD after coronary angiography, we immediately referred the patient to cardiovascular surgeons, and emergent surgery was prepared. Then, both reperfusion therapy for the LMCA in the catheterization laboratory to stabilize the hemodynamics and emergent surgery were prepared simultaneously. The final decision was made by the heart team consisting of interventional cardiologists, cardiovascular surgeons, and other medical staff. All PCI procedures were performed in the cardiac catheterization laboratory. Heparin was given to all patients as a bolus intravenously to achieve an activated clotting time of > 250 s. The guidewires were carefully inserted into the left anterior descending artery and left circumflex artery to avoid false lumen insertion. Plain old balloon angioplasty was performed before stenting as needed. Bare metal stents or drug-eluting stents were deployed under angiography or intravascular ultrasound guidance to completely cover the dissection. Intra-aortic balloon pumping (IABP) or a percutaneous left ventricular support device was used in patients with cardiogenic shock, which was defined as systolic blood pressure < 80 mm Hg or the need for parenteral inotropic or vasoactive medication to maintain systolic blood pressure ≥ 80 mm Hg. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was inserted to patients without return of spontaneous circulation after cardiopulmonary arrest or those with hemodynamic collapse.

Surgical procedures

Patients were transferred to the operating room after PCI and underwent central repair, except for those with poor cardiac function even after PCI or those with neurological manifestations. After the initiation of extracorporeal circulation and the transection of the ascending aorta, blood cardioplegia was infused from the coronary ostium. In patients with localized aortic dissection at the aortic root, direct repair was performed by closing the false channel with surgical glue. In patients with aortic dissection extending to the ascending aorta, ascending aorta replacement, hemiarch replacement, or total arch replacement was performed. In patients, where complete coronary revascularization was not achieved, coronary artery bypass grafting to the left anterior descending artery and/or the left circumflex artery was performed using saphenous vein grafts.

Follow-up

We evaluated in-hospital and 5 year outcomes of patients with LMCA malperfusion caused by AAAD by reviewing the hospital charts and contacting the patients.

Statistical analysis

Data are expressed as mean ± standard deviation for continuous variables. Categorical variables are reported as numbers with relative percentages. SPSS version 25 (International Business Machines, Armonk, NY, USA) was used for all statistical calculations. The data were not analyzed for statistical difference due to the small size of the study population, however.

Results

Study population

In the initial cohort, there were 436 patients with culprit lesions in the LMCA, nine of whom with LMCA malperfusion caused by AAAD were reviewed for this case series.

Patient/clinical characteristics and diagnosis

Baseline patient characteristics of the nine patients are shown in Table 1. No patients had histories of Marfan syndrome, prior aortic dissection or aneurysm, or cardiac surgery. Five of the eight patients with cardiogenic shock had cardiopulmonary arrest due to ventricular fibrillation on arrival, and return of spontaneous circulation was achieved in one patient.
Table 1
Baseline patient characteristics
 
n = 9
Age, yrs
55.4 ± 8.2
Men
8 (89)
Body mass index, kg/m2
25.1 ± 5.9
History
 Hypertension
6 (67)
 Dyslipidemia
3 (33)
 Diabetes
0 (0)
 Smoking
6 (67)
 Atrial fibrillation
1 (11)
 Prior myocardial infarction
1 (11)
 Prior cardiac surgery
0 (0)
Patient status
 ST elevation myocardial infarction
7 (78)
 Ventricular fibrillation
5 (56)
 Cardiogenic shock
8 (89)
 Moderate to severe aortic regurgitation
1 (11)
 Cardiac tamponade
0 (0)
Laboratory data
 Creatinine, mg/dL
1.13 ± 0.31
 Hemoglobin, mg/dL
12.4 ± 3.5
Values are n (%) or mean ± standard deviation
Clinical characteristics and diagnoses are shown in Table 2. Initial presentation was chest pain in seven patients, dyspnea in one patient, and unknown in one patient. The type of acute coronary syndrome was STEMI in seven patient, non-STEMI in one patient, and unknown in one patient. Transthoracic echocardiography showed left ventricular asynergy in all patients and moderate aortic regurgitation in one patient. Only two of the nine patients (22%, Cases 4 and 7) were diagnosed with AAAD before coronary angiography using computed tomography and transthoracic echocardiography, respectively (Fig. 1). The other patients were diagnosed with AAAD after coronary angiography using transesophageal echocardiography, ascending aorta angiography, or intravascular ultrasound (Figs. 2 and 3). Two patients had type A aortic intramural hematoma and the other seven patients type A classic aortic dissection. According to Neri’s classification [1], eight patients had type B and one patient type C. Of the eight patients with Neri’s type B, two patients had LMCA malperfusion caused by false lumen thrombosis.
Table 2
Clinical characteristics and diagnoses
Case no
Age
Sex
Chief complaint
Electrocardiogram
TTE
pH
BE
(mEq/L)
D-dimer
(μg/mL)
Diagnosis before CAG
Diagnostic modality
1
52
M
NA
NA
Asynergy at anteroseptal/posterolateral
NA
NA
NA
NA
NA
Mild aortic regurgitation
EF 35%
2
49
F
Chest pain
ST elevation in I, aVL, V1–V4
Asynergy at anteroseptal
7.359
 + 1.7
0.6
 − 
TEE
Mild aortic regurgitation
EF 40%
3
46
M
Chest pain
ST elevation in I, aVL, V3–V6
Asynergy at anteroseptal
7.246
 − 10.0
47
 − 
AoG
Small pericardial effusion
EF 20%
4
49
M
Chest pain
ST elevation in I, aVL, V2–V6
Asynergy at anterolateral
7.357
 − 2.0
2.8
 + 
CT
EF 25%
5
51
M
Chest pain
ST depression in V2–V6
Asynergy at anterior
7.469
 − 4.1
0.8
 − 
AoG
EF 30%
6
58
M
Chest pain
ST elevation in global induction
Asynergy at anteroseptal/posterolateral
NA
NA
NA
 − 
AoG
Mild aortic regurgitation
EF 15%
7
67
M
Chest and back pain
ST elevation in I, aVR, aVL, V2–V6
Asynergy at anteroseptal
7.379
 − 3.3
6.6
 + 
TTE
Moderate aortic regurgitation
Syncope
EF 40%
Flap
8
69
M
Chest pain
ST elevation in I, aVR, aVL, V1–V6
Asynergy at anteroseptal/posterolateral
7.385
 − 11.6
671
 − 
IVUS
Bilateral leg pain
Small pericardial effusion
EF 30%
9
58
M
Dyspnea
ST elevation in I, aVR, aVL, V1–V5
Asynergy at anteroseptal/posterolateral
7.028
 − 20.4
346
 − 
AoG
EF 20%
AoG aortography, BE base excess, CAG coronary angiography, CT computed tomography, EF ejection fraction, IVUS intravascular ultrasound, NA not available, TEE transesophageal echocardiography, TTE transthoracic echocardiography

Procedures

The procedures are shown in Table 3. Among the eight patients with cardiogenic shock, four required IABP and one a percutaneous left ventricular support device. In all patients, VA-ECMO was used in four patients (44%) requiring persistent ventricular fibrillation, coronary reperfusion was achieved in eight patients (89%), except for one patient, where the guidewire failed to pass through the true lumen (Fig. 4), and stents were implanted in seven patients (78%). Final kissing balloon inflation after LMCA crossover stenting was performed in two patients. Perfusion catheter insertion after plain old balloon angioplasty was performed in only one patient. The final thrombolysis in myocardial infarction (TIMI) score was 3 in four patients, 2 in four patients, and 0 in one patient. Among eight patients who achieved coronary reperfusion, five were immediately transferred to the operating room to undergo central repair, two of whom were treated by direct repair with false lumen closure and the other three were treated by ascending aorta replacement, hemiarch replacement, and total arch replacement, respectively. In three patients, where complete coronary revascularization was not achieved by PCI, coronary artery bypass grafting using saphenous vein grafts was additionally performed. The other four patients (44%) did not undergo surgery because of insufficient cardiac function and VA-ECMO dependence.
Table 3
Procedures and outcomes
Case no
Cardiogenic shock
Systolic blood pressure (mmHg)
CPA
MCS
System
CAG
Neri type
Percutaneous coronary intervention
Onset to balloon time
(min)
Final TIMI flow
Peak CK/CK-MB
(IU/L)
Surgery
EF at discharge
(%)
Outcome
1
 + 
NA
 − 
IABP
Femoral.A
#5 99%
B
LMT-LAD stenting (BMS × 2)
NA
3
NA
Ascending aorta replacement
NA
Alive
7Fr JL 4.0 ST
#6 99%
CABG (SVG–LAD, SVG–LCx)
2
 − 
124
 − 
Femoral.A
#5 99%
B
LMT-LAD stenting (BMS × 3)
183
3
7017/273
Closure of the false channel
49
Alive
7Fr JL 3.5 ST
#6 99%
KBT
CABG (SVG–LCx)
3
 + 
64
 + 
VA-ECMO
Femoral.A
#5 99%
B
LMT stenting (BMS)
278
3
13,901/300 < 
Dead
IABP
7Fr JL 4.0 ST
4
 + 
75
 − 
IABP
Femoral.A
#5 100%
B
POBA + perfusion catheter for LAD and LCx
250
2
9908/203
Closure of the false channel
29
Alive
8Fr JL 4.0
CABG (SVG–LAD, SVG–LCx)
5
 + 
65
 − 
IABP
Femoral.A
#5 99%
B
LMT stenting (BMS)
153
2
3282/230
Hemiarch replacement
49
Alive
7Fr JL 5.0
6
 + 
52
 + 
VA-ECMO
Femoral.A
#1 100%
C
Failure (guidewire failure)
0
NA
Dead
7Fr AL 1.0
#5 100%
7
 + 
80
 + 
Femoral.A
#5 99%
B
LMT–LAD stenting (BMS)
224
3
4951/213
Total arch replacement
48
Alive
7Fr AL 1.0
#6 99%
LMT–LCx stenting (BMS)
#11 99%
KBT
8
 + 
71
 + 
VA-ECMO
Femoral.A
#5 99%
B
LMT stenting (DES)
406
2
NA
Dead
Impella
7Fr SL 4.0
9
 + 
90
 + 
VA-ECMO
Brachial.A
#5 99%
B
LMT–LAD stenting (DES)
206
2
NA
Dead
7Fr SL 4.0
#6 99%
BMS bare metal stent, CABG coronary artery bypass grafting, CK creatine kinase, CK-MB creatine kinase myocardial band, CPA cardiopulmonary arrest, DES drug-eluting stent, EF ejection fraction, IABP intra-aortic balloon pumping, KBT kissing balloon technique, LMT left main trunk, LAD left anterior descending coronary artery, LCx left circumflex coronary artery, MCS mechanical circulatory support, PCI percutaneous coronary intervention, POBA plain old balloon angioplasty, SVG saphenous vein graft; VA-ECMO venoarterial extracorporeal membrane oxygenation

Outcomes

The outcomes are shown in Table 3. Four patients (44%) died in hospital, without VA-ECMO weaning. The other five patients (56%) survived to discharge after successful PCI and surgery, one of whom developed cerebral infarction after surgery. Between survivors and non-survivors, non-survivors had higher D-dimer levels (354.7 vs. 2.7 μg/mL) and more severe metabolic acidosis (pH 7.220 ± 0.180 vs. 7.391 ± 0.053; base excess − 14.0 ± 5.6 vs. − 1.9 ± 2.6 mEq/L). Among the five survivors, two received the diagnosis of AAAD before coronary angiography and three were supported by IABP alone. The mean left ventricular ejection fraction at discharge was 44 ± 10%. All five survivors were alive at 5 year follow-up, one of whom underwent thoracic endovascular aortic repair for aortic aneurysm due to residual dissection (Case 7). No survivors required either hospitalization for heart failure or target vessel revascularization during the follow-up period.

Discussion

This case series is the first report to systematically investigate the clinical characteristics, procedures, and outcomes in patients undergoing PCI for LMCA malperfusion caused by AAAD. The main findings of this study were as follows: first, AAAD was difficult to diagnose accurately in the emergency room; second, the in-hospital mortality rate in AAAD patients with LMCA malperfusion undergoing PCI was 44%; and third, patients with poor prognosis (non-survivors) tended to have cardiopulmonary arrest requiring VA-ECMO, higher D-dimer levels, and severe metabolic acidosis.
Clinical presentation of AAAD is similar to that of acute coronary syndrome, which frequently results in misdiagnosis [13]. In this study, seven (78%) of the nine patients were diagnosed with acute coronary syndrome in the emergency room and were transferred to the cardiac catheterization laboratory. All patients underwent bedside transthoracic echocardiography; however, a mobile flap was found in the ascending aorta of only one patient (Case 7). According to previous research, three important findings of transthoracic echocardiography indicating AAAD are aortic root dilation, aortic eccentric regurgitation, and pericardial effusion [14]. Because both two patients who were diagnosed with AAAD before coronary angiography survived to discharge, early diagnosis of AAAD may contribute to raise the survival rate. However, diagnosing AAAD in patients with hemodynamic instability is difficult in emergency situations. In this study, although seven of the nine patients were diagnosed with AAAD after coronary angiography, reperfusion therapy in the LMCA was performed without any delay. Because hemodynamic stabilization has to be the top priority, the initial treatment strategy for this condition is similar to that for acute coronary syndrome with cardiogenic shock. In patients with right coronary artery malperfusion who have less hemodynamic instability and lower mortality, surgical aortic repair should be selected as an initial treatment strategy [3]. If AAAD is diagnosed prior to coronary angiography, the patient may benefit from being transported to a hybrid operating room immediately and undergoing reperfusion therapy for the LMCA and subsequent surgical aortic repair.
In this study, both the in-hospital and 5 year follow-up survival rates were 56% (5/9 patients), without either hospitalization for heart failure or target vessel revascularization, which were better than those of previous studies on patients with acute myocardial infarction due to LMCA disease (in-hospital: approximately 50%; 6 month follow-up: 41%) [1517]. Comorbid aortic dissection may not affect the in-hospital and long-term outcomes, and early reperfusion therapy may contribute to preserve left ventricular function and prevent heart failure. In addition, the etiology of myocardial ischemia in our study population was not atherosclerotic disease, which may have led to the favorable long-term outcomes.
The presence of myocardial ischemia, cardiopulmonary arrest on arrival, and LMCA ischemia have been reported to be risk factors for operative death and postoperative low cardiac output syndrome in AAAD patients [3]. In this study, eight (89%) of the nine patients had cardiogenic shock, which indicates that our study population suffered severe hemodynamic instability. Fatal myocardial ischemia tends to occur before surgical reconstruction of coronary blood flow. According to previous research, the shorter door-to-balloon time decreases the mortality rate in STEMI patients by reducing myocardial damages [7, 18, 19]. In this study, because all patients with severe metabolic acidosis and hemodynamic deterioration requiring VA-ECMO could not be saved, preoperative PCI may be an effective approach to reduce myocardial damages and stabilize hemodynamics in patients with LMCA malperfusion caused by AAAD. IABP as circulatory support is considered a contraindication for AAAD patients because of the concerns over flap extension and aortic rupture. In this study, the four patients were supported by IABP to maintain hemodynamic stability and had no adverse events associated with IABP, and the three patients supported by IABP alone were successfully treated by PCI and subsequent surgery and survived to discharge. Using IABP may be one of the strategies to prevent prolonged cardiogenic shock and subsequent progressive acidosis.
The current study has several limitations. First, this is a retrospective, single-center, observational study with a small study population. Larger prospective studies are warranted to confirm the findings of this study. Second, surgical strategies for AAAD patients with LMCA malperfusion were not assessed. Third, AAAD patients with LMCA malperfusion who had been directly transferred from the emergency room to the operating room were not included. Fourth, the differences in the clinical characteristics between AAAD patients with LMCA malperfusion and acute coronary syndrome patients with LMCA atherosclerosis were not evaluated in this case series. Finally, accurate drug information on perioperative antithrombotic therapy could not be collected.

Conclusions

LMCA malperfusion caused by AAAD seemed to have clinical presentations and electrocardiogram changes similar to acute coronary syndrome. PCI and subsequent surgical aortic repair saved the lives of all AAAD patients with LMCA malperfusion who had not required VA-ECMO.

Acknowledgements

The authors appreciate Miho Kobayashi, Makiko Kanaike, and Takako Yukiyoshi for their assistance with the manuscript.

Declarations

Conflict of interest

The authors have no conflicts of interest to disclose.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Neri E, Toscano T, Papalia U, Frati G, Massetti M, Capannini G, et al. Proximal aortic dissection with coronary malperfusion: presentation, management, and outcome. J Thorac Cardiovasc Surg. 2001;121(3):552–60.CrossRef Neri E, Toscano T, Papalia U, Frati G, Massetti M, Capannini G, et al. Proximal aortic dissection with coronary malperfusion: presentation, management, and outcome. J Thorac Cardiovasc Surg. 2001;121(3):552–60.CrossRef
2.
Zurück zum Zitat Kawahito K, Adachi H, Murata S, Yamaguchi A, Ino T. Coronary malperfusion due to type A aortic dissection: mechanism and surgical management. Ann Thorac Surg. 2003;76(5):1471–6 (discussion 1476).CrossRef Kawahito K, Adachi H, Murata S, Yamaguchi A, Ino T. Coronary malperfusion due to type A aortic dissection: mechanism and surgical management. Ann Thorac Surg. 2003;76(5):1471–6 (discussion 1476).CrossRef
3.
Zurück zum Zitat Imoto K, Uchida K, Karube N, Yasutsune T, Cho T, Kimura K, et al. Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection. Eur J Cardiothorac Surg. 2013;44(3):419–24 (discussion 424–5).CrossRef Imoto K, Uchida K, Karube N, Yasutsune T, Cho T, Kimura K, et al. Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection. Eur J Cardiothorac Surg. 2013;44(3):419–24 (discussion 424–5).CrossRef
4.
Zurück zum Zitat Uchida K, Karube N, Minami T, Cho T, Matsuki Y, Nemoto H, et al. Treatment of coronary malperfusion in type A acute aortic dissection. Gen Thorac Cardiovasc Surg. 2018;66(11):621–5.CrossRef Uchida K, Karube N, Minami T, Cho T, Matsuki Y, Nemoto H, et al. Treatment of coronary malperfusion in type A acute aortic dissection. Gen Thorac Cardiovasc Surg. 2018;66(11):621–5.CrossRef
5.
Zurück zum Zitat Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine. ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American college of cardiology foundation/american heart association task force on practice guidelines, American association for thoracic surgery, American college of radiology, American stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons,and society for vascular medicine. J Am Coll Cardiol. 2010;55(14):e27–129. https://doi.org/10.1016/j.jacc.2010.02.015 (Erratum in: J Am Coll Cardiol. 2013 Sep 10;62(11):1039–40).CrossRef Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American College of Radiology; American Stroke Association; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Thoracic Surgeons; Society for Vascular Medicine. ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the American college of cardiology foundation/american heart association task force on practice guidelines, American association for thoracic surgery, American college of radiology, American stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons,and society for vascular medicine. J Am Coll Cardiol. 2010;55(14):e27–129. https://​doi.​org/​10.​1016/​j.​jacc.​2010.​02.​015 (Erratum in: J Am Coll Cardiol. 2013 Sep 10;62(11):1039–40).CrossRef
6.
Zurück zum Zitat Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.CrossRef Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the European society of cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.CrossRef
7.
Zurück zum Zitat Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, et al. National Cardiovascular Data Registry. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009;338:b1807.CrossRef Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, et al. National Cardiovascular Data Registry. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009;338:b1807.CrossRef
8.
Zurück zum Zitat Barabas M, Gosselin G, Crépeau J, Petitclerc R, Cartier R, Théroux P. Left main stenting-as a bridge to surgery-for acute type A aortic dissection and anterior myocardial infarction. Catheter Cardiovasc Interv. 2000;51(1):74–7.CrossRef Barabas M, Gosselin G, Crépeau J, Petitclerc R, Cartier R, Théroux P. Left main stenting-as a bridge to surgery-for acute type A aortic dissection and anterior myocardial infarction. Catheter Cardiovasc Interv. 2000;51(1):74–7.CrossRef
9.
Zurück zum Zitat Imoto K, Uchida K, Suzuki S, Isoda S, Karube N, Kimura K. Stenting of a left main coronary artery dissection and stent-graft implantation for acute type A aortic dissection. J Endovasc Ther. 2005;12(2):258–61.CrossRef Imoto K, Uchida K, Suzuki S, Isoda S, Karube N, Kimura K. Stenting of a left main coronary artery dissection and stent-graft implantation for acute type A aortic dissection. J Endovasc Ther. 2005;12(2):258–61.CrossRef
10.
Zurück zum Zitat Ruisi M, Fallahi A, Lala M, Kanei Y. Aortic dissection presenting as acute subtotal left main coronary artery occlusion: a case approach and review of the literature. J Clin Med Res. 2015;7(5):356–60.CrossRef Ruisi M, Fallahi A, Lala M, Kanei Y. Aortic dissection presenting as acute subtotal left main coronary artery occlusion: a case approach and review of the literature. J Clin Med Res. 2015;7(5):356–60.CrossRef
11.
Zurück zum Zitat Shimamoto T, Komiya T. Clinical dilemma in the surgical treatment of organ malperfusion caused by acute type A aortic dissection. Gen Thorac Cardiovasc Surg. 2014;62(7):398–406.CrossRef Shimamoto T, Komiya T. Clinical dilemma in the surgical treatment of organ malperfusion caused by acute type A aortic dissection. Gen Thorac Cardiovasc Surg. 2014;62(7):398–406.CrossRef
12.
Zurück zum Zitat Hanaki Y, Yumoto K, I S, Aoki H, Fukuzawa T, Watanabe T, Kato K. Coronary stenting with cardiogenic shock due to acute ascending aortic dissection. World J Cardiol. 2015;7(2):104–10.CrossRef Hanaki Y, Yumoto K, I S, Aoki H, Fukuzawa T, Watanabe T, Kato K. Coronary stenting with cardiogenic shock due to acute ascending aortic dissection. World J Cardiol. 2015;7(2):104–10.CrossRef
13.
Zurück zum Zitat Hansen MS, Nogareda GJ, Hutchison SJ. Frequency of and inappropriate treatment of misdiagnosis of acute aortic dissection. Am J Cardiol. 2007;99(6):852–6.CrossRef Hansen MS, Nogareda GJ, Hutchison SJ. Frequency of and inappropriate treatment of misdiagnosis of acute aortic dissection. Am J Cardiol. 2007;99(6):852–6.CrossRef
14.
Zurück zum Zitat Güvenç TS, Erer HB, Çetin R, Hasdemir H, İlhan E, Türkkan C, et al. Acute aortic regurgitation with myocardial infarction: an important clue for aortic dissection. J Emerg Med. 2013;44(1):e5-8.CrossRef Güvenç TS, Erer HB, Çetin R, Hasdemir H, İlhan E, Türkkan C, et al. Acute aortic regurgitation with myocardial infarction: an important clue for aortic dissection. J Emerg Med. 2013;44(1):e5-8.CrossRef
15.
Zurück zum Zitat Hashimoto S, Shiraishi J, Nakamura T, Nishikawa M, Yanagiuchi T, Ito D, et al. Survivors of acute myocardial infarction at left main trunk undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther. 2016;31(2):89–95.CrossRef Hashimoto S, Shiraishi J, Nakamura T, Nishikawa M, Yanagiuchi T, Ito D, et al. Survivors of acute myocardial infarction at left main trunk undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther. 2016;31(2):89–95.CrossRef
16.
Zurück zum Zitat Neri R, Migliorini A, Moschi G, Valenti R, Dovellini EV, Antoniucci D. Percutaneous reperfusion of left main coronary disease complicated by acute myocardial infarction. Catheter Cardiovasc Interv. 2002;56(1):31–4.CrossRef Neri R, Migliorini A, Moschi G, Valenti R, Dovellini EV, Antoniucci D. Percutaneous reperfusion of left main coronary disease complicated by acute myocardial infarction. Catheter Cardiovasc Interv. 2002;56(1):31–4.CrossRef
17.
Zurück zum Zitat Marso SP, Steg G, Plokker T, Holmes D, Park SJ, Kosuga K, et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected left main trunk intervention multi-center assessment. Am J Cardiol. 1999;83(11):1513–7.CrossRef Marso SP, Steg G, Plokker T, Holmes D, Park SJ, Kosuga K, et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected left main trunk intervention multi-center assessment. Am J Cardiol. 1999;83(11):1513–7.CrossRef
18.
Zurück zum Zitat Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.CrossRef Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13–20.CrossRef
19.
Zurück zum Zitat Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(23):2145–53.CrossRef Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(23):2145–53.CrossRef
Metadaten
Titel
Percutaneous coronary intervention for left main coronary artery malperfusion in acute type A aortic dissection
verfasst von
Yuya Taguchi
Shunsuke Kubo
Akihiro Ikuta
Kohei Osakada
Makoto Takamatsu
Kotaro Takahashi
Masanobu Ohya
Takenobu Shimada
Katsuya Miura
Ryosuke Murai
Takeshi Tada
Hiroyuki Tanaka
Yasushi Fuku
Tsuyoshi Goto
Tatsuhiko Komiya
Kazushige Kadota
Publikationsdatum
13.07.2021
Verlag
Springer Singapore
Erschienen in
Cardiovascular Intervention and Therapeutics / Ausgabe 2/2022
Print ISSN: 1868-4300
Elektronische ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-021-00793-4

Weitere Artikel der Ausgabe 2/2022

Cardiovascular Intervention and Therapeutics 2/2022 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.